144 related articles for article (PubMed ID: 35199566)
21. The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC.
Shen K; Wei Y; Lv T; Song Y; Jiang X; Lu Z; Zhan P; Wang X; Fan M; Lu W
BMC Bioinformatics; 2021 Sep; 22(1):471. PubMed ID: 34587898
[TBL] [Abstract][Full Text] [Related]
22. Low PD-1 Expression in Cytotoxic CD8
Mazzaschi G; Madeddu D; Falco A; Bocchialini G; Goldoni M; Sogni F; Armani G; Lagrasta CA; Lorusso B; Mangiaracina C; Vilella R; Frati C; Alfieri R; Ampollini L; Veneziani M; Silini EM; Ardizzoni A; Urbanek K; Aversa F; Quaini F; Tiseo M
Clin Cancer Res; 2018 Jan; 24(2):407-419. PubMed ID: 29074606
[No Abstract] [Full Text] [Related]
23. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer.
Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J
Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
26. Dynamic changes in PD-L1 expression and CD8
Choe EA; Cha YJ; Kim JH; Pyo KH; Hong MH; Park SY; Shim HS; Jung I; Lee CY; Cho BC; Kim HR
Lung Cancer; 2019 Oct; 136():30-36. PubMed ID: 31421259
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
Feng Z; Yin Y; Liu B; Zheng Y; Shi D; Zhang H; Qin J
Cancer Control; 2022; 29():10732748221076682. PubMed ID: 35212236
[TBL] [Abstract][Full Text] [Related]
28. ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC.
Yang Z; Tian H; Bie F; Xu J; Zhou Z; Yang J; Li R; Peng Y; Bai G; Tian Y; Chen Y; Liu L; Fan T; Xiao C; Zheng Y; Zheng B; Wang J; Li C; Gao S; He J
Front Immunol; 2021; 12():788985. PubMed ID: 34992605
[TBL] [Abstract][Full Text] [Related]
29. Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.
Ma Q; Geng K; Xiao P; Zeng L
Biomed Res Int; 2021; 2021():5963868. PubMed ID: 34518802
[TBL] [Abstract][Full Text] [Related]
30. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
31. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment.
Zhu Z; Ye W; Wu X; Lin S; Xu J; Li L; Li J; Wang H; Huang Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350431
[TBL] [Abstract][Full Text] [Related]
33. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
[TBL] [Abstract][Full Text] [Related]
34. High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
Oh MS; Anker JF; Chae YK
Cancer Treat Res Commun; 2021; 27():100317. PubMed ID: 33711637
[TBL] [Abstract][Full Text] [Related]
35. KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.
Liu YZ; Yang H; Cao J; Jiang YY; Hao JJ; Xu X; Cai Y; Wang MR
Sci Rep; 2016 Apr; 6():24786. PubMed ID: 27098511
[TBL] [Abstract][Full Text] [Related]
36. PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy.
Chen K; Cheng G; Zhang F; Zhu G; Xu Y; Yu X; Huang Z; Fan Y
Lung Cancer; 2020 Apr; 142():98-105. PubMed ID: 32120230
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.
Liu SY; Dong ZY; Wu SP; Xie Z; Yan LX; Li YF; Yan HH; Su J; Yang JJ; Zhou Q; Zhong WZ; Tu HY; Yang XN; Zhang XC; Wu YL
Lung Cancer; 2018 Nov; 125():86-92. PubMed ID: 30429043
[TBL] [Abstract][Full Text] [Related]
38. Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer.
Backman M; Strell C; Lindberg A; Mattsson JSM; Elfving H; Brunnström H; O'Reilly A; Bosic M; Gulyas M; Isaksson J; Botling J; Kärre K; Jirström K; Lamberg K; Pontén F; Leandersson K; Mezheyeuski A; Micke P
Eur J Cancer; 2023 May; 185():40-52. PubMed ID: 36963351
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
40. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]